KEGG   PATHWAY: oga05213
Entry
oga05213                    Pathway                                
Name
Endometrial cancer - Otolemur garnettii (small-eared galago)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
oga05213  Endometrial cancer
oga05213

Disease
H00026  Endometrial cancer
Organism
Otolemur garnettii (small-eared galago) [GN:oga]
Gene
100940553  TCF7L1; transcription factor 7-like 1 [KO:K04490]
100941062  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
100941755  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
100943020  SOS2; son of sevenless homolog 2 [KO:K03099]
100943434  TCF7L2; transcription factor 7-like 2 isoform X11 [KO:K04491]
100944025  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
100945977  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100946725  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
100946928  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
100947138  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
100947392  TCF7; transcription factor 7 isoform X1 [KO:K02620]
100947929  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
100948347  FOXO3; forkhead box protein O3 [KO:K09408]
100948701  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
100949181  ELK1; ETS domain-containing protein Elk-1 isoform X2 [KO:K04375]
100949583  NRAS; GTPase NRas isoform X1 [KO:K07828]
100949858  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
100950210  PDPK1; 3-phosphoinositide-dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
100950293  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
100950302  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
100950782  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
100950842  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma isoform X2 [KO:K04402]
100951533  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
100951644  HRAS; GTPase HRas isoform X1 [KO:K02833]
100952580  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2 [KO:K02649]
100952751  GSK3B; glycogen synthase kinase-3 beta [KO:K03083] [EC:2.7.11.26]
100952981  MYC; myc proto-oncogene protein [KO:K04377]
100953050  KRAS; GTPase KRas isoform X3 [KO:K07827]
100953367  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
100953964  ERBB2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
100954109  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
100955276  AKT3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100955336  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
100956072  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X2 [KO:K04369] [EC:2.7.12.2]
100956838  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649]
100957285  BAX; apoptosis regulator BAX [KO:K02159]
100957343  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
100957904  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
100958318  [KO:K05689]
100958411  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
100958517  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
100958529  ILK; integrin-linked protein kinase [KO:K06272] [EC:2.7.11.1]
100958947  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
100959283  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
100959686  EGF; pro-epidermal growth factor [KO:K04357]
100959825  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
100959926  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
100960110  CTNNA1; catenin alpha-1 [KO:K05691]
100960331  CTNNA2; catenin alpha-2 isoform X3 [KO:K05691]
100962306  BAD; bcl2-associated agonist of cell death [KO:K02158]
100962402  DDB2; DNA damage-binding protein 2 [KO:K10140]
100963622  TP53; cellular tumor antigen p53 [KO:K04451]
100964150  AXIN1; axin-1 isoform X2 [KO:K02157]
100964757  AXIN2; axin-2 [KO:K04385]
100966233  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
100966348  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
100966689  CTNNB1; catenin beta-1 [KO:K02105]
100967150  CTNNA3; catenin alpha-3 [KO:K05691]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
oga04010  MAPK signaling pathway
oga04012  ErbB signaling pathway
oga04060  Cytokine-cytokine receptor interaction
oga04110  Cell cycle
oga04115  p53 signaling pathway
oga04151  PI3K-Akt signaling pathway
oga04310  Wnt signaling pathway
oga04520  Adherens junction
KO pathway
ko05213   

DBGET integrated database retrieval system